Cargando…
Metabolic Profiling of Patients with Schizophrenia
Kaddurah-Daouk discusses a new study that found that patients with schizophrenia have an abnormal cerebrospinal fluid composition. In half of the patients, the composition returned to normal with antipsychotic therapy.
Autor principal: | Kaddurah-Daouk, Rima |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1551921/ https://www.ncbi.nlm.nih.gov/pubmed/16933969 http://dx.doi.org/10.1371/journal.pmed.0030363 |
Ejemplares similares
-
Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics
por: McEvoy, Joseph, et al.
Publicado: (2013) -
Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naïve Patients with Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2010) -
Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
por: Beger, Richard D., et al.
Publicado: (2020) -
Associations between Purine Metabolites and Clinical Symptoms in Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2012) -
Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023)